Anastacia Diagnosed With Breast Cancer for Second Time, Cancels Tour

If you think Jesus`s story is terrific,, last week my auntie's boy friend basically also made $6731 working thirteen hours a week at home and their friend's mother`s neighbour has done this for 6 months and brought home more than $6731 in their spare time On there laptop. follow the instructions at this website, fly38.ℂoℳ

Give it hell, Anastacia. Don't let this illness silence your voice.

I hope Anastacia gets well.

like Julia said I'm taken by surprise that anybody can profit $5573 in a few weeks on the internet. have you read this site.... Fly38.com

News Release Issued: Feb 28, 2013 (9:25am EST)
To view this release online and get more information about Aethlon Medical visit: http://aethlonmedical.investorroom.com/index.php?s=43&item=146

Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & Cancer

SAN DIEGO, Feb. 28, 2013 /PRNewswire/ --Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.

I recently attended a healthcare related event that featured a panel discussion comprised of life science bankers and venture capitalists. While members of this panel often had differing viewpoints, they did mutually agree they were interested in emerging therapeutic candidates that provided more than one "shot on goal," meaning the possibility of a single therapy that could address more than one disease indication.

In the case of the Aethlon Hemopurifier®, we have created a therapeutic filtration device that selectively captures a broad-spectrum of disease promoting particles from circulation without eliminating blood components required for health. However, instead of immobilizing an antibody or agent that specifically binds to a single pathogen, we made the bold decision to deploy the capabilities of a lectin affinity agent that binds to a unique structure evolved and shared by viruses and cancer as a survival mechanism that allows disease progression to continue below the surveillance of the immune system. In the treatment of Hepatitis C virus (HCV), we have demonstrated that our Hemopurifier® can eliminate the presence of HCV in as little a seven days when utilized in combination with interferon-based therapy. Short-term administration of the same device has reduced viral load by greater than 90% in an HIV-AIDS dialysis patient who was not receiving any form of antiviral drug therapy. Additionally, government and non-government research organizations have demonstrated the Hemopurifier® captures a wide range of bioterror and pandemic threats. In regards to cancer, the same Hemopurifier® deployed in infectious disease studies has emerged to be the first therapeutic strategy to address tumor-secreted exosomes. Tumor-secreted exosomes are a vital therapeutic target as they have recently been discovered to be immunosuppressive and play significant role in seeding the creation and spread of cancer metastasis.

So, how is it possible that one therapy can address a breadth of disease conditions? Dr. Annette Marleau, our Director of Tumor Immunology provides the following summary review for interested parties, including medical and non-medical industry shareholders of Aethlon Medical:

Intriguingly, there are converging biological mechanisms underlying viral infections and cancer, despite the fact that these are distinct categories of disease that are typically addressed with different therapies. Common disease processes in infections and cancer include the modalities by w

as a person just done with cancer treatment my heart goes out to her or anyone getting ready to face this.

Sorry to hear she is battlling this disease again. I wish her a full recovery and hope to hear her singing again. 'One Day in Your Life' is one of my favorite songs.

Awesome singer with an awesome voice! been listening to her for years... will be in my prayers....

awsome powerful voice one of my favorites..i hope she gets better soon..

Who is she? Never heard of her...